{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:15:15Z","timestamp":1777630515894,"version":"3.51.4"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010854","name":"Jiangsu Provincial Health Commission","doi-asserted-by":"publisher","award":["Z2023055"],"award-info":[{"award-number":["Z2023055"]}],"id":[{"id":"10.13039\/501100010854","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["SJCX23_1410"],"award-info":[{"award-number":["SJCX23_1410"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007166","name":"JIangsu Education Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803609"],"award-info":[{"award-number":["81803609"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.lfs.2026.124283","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:57:04Z","timestamp":1771516624000},"page":"124283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Emodin retards renal cyst progression in ADPKD by inhibiting cell proliferation and decreasing oxidative stress"],"prefix":"10.1016","volume":"391","author":[{"given":"Yuqi","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongtao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zifan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kequan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10174","key":"10.1016\/j.lfs.2026.124283_bb0005","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease","volume":"393","author":"Cornec-Le G","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lfs.2026.124283_bb0010","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-019-1241-1","article-title":"Revisiting racial differences in ESRD due to ADPKD in the United States","volume":"20","author":"Murphy","year":"2019","journal-title":"BMC Nephrol."},{"issue":"4","key":"10.1016\/j.lfs.2026.124283_bb0015","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.ajkd.2014.05.020","article-title":"ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010","volume":"64","author":"Reule","year":"2014","journal-title":"Am. J. Kidney Dis."},{"issue":"10","key":"10.1016\/j.lfs.2026.124283_bb0020","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1681\/ASN.2018060590","article-title":"A practical guide for treatment of rapidly progressive ADPKD with Tolvaptan","volume":"29","author":"Chebib","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"20","key":"10.1016\/j.lfs.2026.124283_bb0025","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.lfs.2026.124283_bb0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000474961","article-title":"Treatment of persistent gross hematuria with tranexamic acid in autosomal dominant polycystic kidney disease","volume":"42","author":"Yao","year":"2017","journal-title":"Kidney Blood Press. Res."},{"issue":"1","key":"10.1016\/j.lfs.2026.124283_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18104-5","article-title":"Cyst growth in ADPKD is prevented by pharmacological and genetic inhibition of TMEM16A in vivo","volume":"11","author":"Cabrita","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2026.124283_bb0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-981-10-2041-4_2","article-title":"Genetic mechanisms of ADPKD","volume":"933","author":"Kim","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"12","key":"10.1016\/j.lfs.2026.124283_bb0045","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41588-021-00946-4","article-title":"Renal plasticity revealed through reversal of polycystic kidney disease in mice","volume":"53","author":"Dong","year":"2021","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.lfs.2026.124283_bb0050","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrneph.2015.46","article-title":"The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease","volume":"11","author":"Seeger-Nukpezah","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"issue":"12","key":"10.1016\/j.lfs.2026.124283_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27123837","article-title":"Potential application of Gambogic acid for retarding renal cyst progression in polycystic kidney disease","volume":"27","author":"Khunpatee","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"9","key":"10.1016\/j.lfs.2026.124283_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2025.103655","article-title":"Antiproliferative effects of dihydrotanshinone I on autosomal dominant polycystic kidney disease via immunomodulation","volume":"392","author":"Mahendran","year":"2025","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.lfs.2026.124283_bb0065","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41401-022-00937-z","article-title":"1-Indanone retards cyst development in ADPKD mouse model by stabilizing tubulin and down-regulating anterograde transport of cilia","volume":"44","author":"Li","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.lfs.2026.124283_bb0070","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.kint.2017.04.013","article-title":"Ganoderma triterpenes retard renal cyst development by downregulating Ras\/MAPK signaling and promoting cell differentiation","volume":"92","author":"Su","year":"2017","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.lfs.2026.124283_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165897","article-title":"Berberine and Emodin abrogates breast cancer growth and facilitates apoptosis through inactivation of SIK3-induced mTOR and Akt signaling pathway","volume":"1866","author":"Ponnusamy","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"2","key":"10.1016\/j.lfs.2026.124283_bb0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10637-019-00777-5","article-title":"Emodin, a natural anthraquinone, suppresses liver cancer in vitro and in vivo by regulating VEGFR(2) and miR-34a","volume":"38","author":"Bai","year":"2020","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.lfs.2026.124283_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116509","article-title":"The LAMB3-EGFR signaling pathway mediates synergistic anti-cancer effects of berberine and emodin in pancreatic cancer","volume":"228","author":"Xu","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.lfs.2026.124283_bb0090","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10157-021-02111-x","article-title":"Natural-derived compounds and their mechanisms in potential autosomal dominant polycystic kidney disease (ADPKD) treatment","volume":"25","author":"Mahendran","year":"2021","journal-title":"Clin. Exp. Nephrol."},{"issue":"7","key":"10.1016\/j.lfs.2026.124283_bb0095","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/carcin\/bgt099","article-title":"Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors","volume":"34","author":"Jelassi","year":"2013","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.lfs.2026.124283_bb0100","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3892\/ol.2016.4902","article-title":"Emodin mitigates the oxidative stress induced by cisplatin in osteosarcoma MG63 cells","volume":"12","author":"Yan","year":"2016","journal-title":"Oncol. Lett."},{"issue":"11","key":"10.1016\/j.lfs.2026.124283_bb0105","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1021\/acs.jmedchem.2c00011","article-title":"Long residence time at the vasopressin V(2) receptor translates into superior inhibitory effects in ex vivo and in vivo models of autosomal dominant polycystic kidney disease","volume":"65","author":"Zhang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2026.124283_bb0110","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.pbb.2010.09.009","article-title":"The anthraquinone derivative emodin attenuates methamphetamine-induced hyperlocomotion and startle response in rats","volume":"97","author":"Mizuno","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.lfs.2026.124283_bb0115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.21010\/ajtcam.v14i2.10","article-title":"Emodin downregulates cell proliferation markers during DMBA induced oral carcinogenesis in golden Syrian hamsters","volume":"14","author":"Manimaran","year":"2017","journal-title":"Afr. J. Tradit. Complement. Altern. Med."},{"key":"10.1016\/j.lfs.2026.124283_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116200","article-title":"Notch3 as a novel therapeutic target for the treatment of ADPKD by regulating cell proliferation and renal cyst development","volume":"224","author":"Su","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.lfs.2026.124283_bb0125","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/hmg\/ddn039","article-title":"Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1","volume":"17","author":"Shibazaki","year":"2008","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.lfs.2026.124283_bb0130","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s42255-020-0227-4","article-title":"Super-enhancer-driven metabolic reprogramming promotes cystogenesis in autosomal dominant polycystic kidney disease","volume":"2","author":"Mi","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.lfs.2026.124283_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S000711452510620X","article-title":"Dietary ratios of medium-chain to long-chain fatty acids influence growth performance, gut barrier function, and microbiota in weaned piglets","author":"Wang","year":"2025","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.lfs.2026.124283_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2022.153160","article-title":"Organophosphate flame retardants induce oxidative stress and chop\/caspase 3-related apoptosis via Sod1\/p53\/Map3k6\/Fkbp5 in NCI-1975 cells","volume":"819","author":"Meng","year":"2022","journal-title":"Sci. Total Environ."},{"issue":"554","key":"10.1016\/j.lfs.2026.124283_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba3613","article-title":"Activation of NRF2 ameliorates oxidative stress and cystogenesis in autosomal dominant polycystic kidney disease","volume":"12","author":"Lu","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lfs.2026.124283_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116445","article-title":"Mechanical stress reduces secreted frizzled-related protein expression and promotes temporomandibular joint osteoarthritis via Wnt\/beta-catenin signaling","volume":"161","author":"Cai","year":"2022","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.lfs.2026.124283_bb0155","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.32604\/or.2025.067638","article-title":"MINDY1 induces PD-L1 deubiquitination to promote immune escape in hepatocellular carcinoma by the Wnt\/beta-catenin pathway","volume":"33","author":"Song","year":"2025","journal-title":"Oncol. Res."},{"issue":"5","key":"10.1016\/j.lfs.2026.124283_bb0160","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1159\/000430160","article-title":"The effect of cAMP-PKA activation on TGF-beta1-induced profibrotic signaling","volume":"36","author":"Weng","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"3","key":"10.1016\/j.lfs.2026.124283_bb0165","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/gfi181","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)","volume":"21","author":"Wahl","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/j.lfs.2026.124283_bb0170","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1073\/pnas.1011498108","article-title":"Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis","volume":"108","author":"Takiar","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.lfs.2026.124283_bb0175","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/MNH.0000000000000079","article-title":"Jak inhibition and progressive kidney disease","volume":"24","author":"Brosius","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"2","key":"10.1016\/j.lfs.2026.124283_bb0180","doi-asserted-by":"crossref","first-page":"C522","DOI":"10.1152\/ajpcell.00163.2010","article-title":"c-Src inactivation reduces renal epithelial cell-matrix adhesion, proliferation, and cyst formation","volume":"301","author":"Elliott","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"11","key":"10.1016\/j.lfs.2026.124283_bb0185","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1681\/ASN.2016111232","article-title":"Bosutinib versus placebo for autosomal dominant polycystic kidney disease","volume":"28","author":"Tesar","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.lfs.2026.124283_bb0190","doi-asserted-by":"crossref","first-page":"F944","DOI":"10.1152\/ajprenal.00387.2010","article-title":"Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells","volume":"299","author":"Yamaguchi","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"6","key":"10.1016\/j.lfs.2026.124283_bb0195","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1681\/ASN.2004090800","article-title":"Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease","volume":"17","author":"Omori","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.lfs.2026.124283_bb0200","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/jcmm.13091","article-title":"Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1\/cyclin axis","volume":"21","author":"Li","year":"2017","journal-title":"J. Cell. Mol. Med."},{"issue":"7","key":"10.1016\/j.lfs.2026.124283_bb0205","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/j.1600-6143.2010.03152.x","article-title":"Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: what is the appropriate serum level?","volume":"10","author":"Canaud","year":"2010","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.lfs.2026.124283_bb0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2011.87","article-title":"WNT\/beta-catenin signaling in polycystic kidney disease","volume":"80","author":"Wuebken","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2026.124283_bb0215","article-title":"Shaoyao decoction promotes ISCs proliferation by activating Wnt\/beta-catenin and YAP1\/TAZ signaling to enhance epithelial regeneration in damp-heat colitis","author":"Yang","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124283_bb0220","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1039\/D1FO02583J","article-title":"Gamma-Tocotrienol induced the proliferation and differentiation of MC3T3-E1 cells through the stimulation of the Wnt\/beta-catenin signaling pathway[J]","volume":"13","author":"Xu","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.lfs.2026.124283_bb0225","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0091-679X(08)94014-0","article-title":"Polycystic kidney disease, cilia, and planar polarity","volume":"94","author":"Menezes","year":"2009","journal-title":"Methods Cell Biol."},{"issue":"5","key":"10.1016\/j.lfs.2026.124283_bb0230","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95874","article-title":"Canonical Wnt inhibitors ameliorate cystogenesis in a mouse ortholog of human ADPKD","volume":"3","author":"Li","year":"2018","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.lfs.2026.124283_bb0235","article-title":"Activation of NRF2 signaling pathway delays the progression of hyperuricemic nephropathy by reducing oxidative stress","volume":"12","author":"Qiao","year":"2023","journal-title":"Antioxidants (Basel)"},{"issue":"15","key":"10.1016\/j.lfs.2026.124283_bb0240","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1111\/bph.15834","article-title":"Leonurine alleviates ferroptosis in cisplatin-induced acute kidney injury by activating the Nrf2 signalling pathway","volume":"179","author":"Hu","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2026.124283_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2024.102670","article-title":"Dental pulp stem cells derived exosomes inhibit ferroptosis via regulating the Nrf2-keap1\/GPX4 signaling pathway to ameliorate chronic kidney disease injury","volume":"93","author":"Luo","year":"2025","journal-title":"Tissue Cell"},{"issue":"2","key":"10.1016\/j.lfs.2026.124283_bb0250","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1681\/ASN.2018010039","article-title":"Lipid peroxidation drives renal cyst growth in vitro through activation of TMEM16A","volume":"30","author":"Schreiber","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124283_bb0255","article-title":"Obacunone retards renal cyst development in autosomal dominant polycystic kidney disease by activating NRF2","volume":"11","author":"Qiu","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"10.1016\/j.lfs.2026.124283_bb0260","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101270RR","article-title":"Antioxidant enzyme peroxiredoxin 5 regulates cyst growth and ciliogenesis via modulating Plk1 stability","volume":"36","author":"Agborbesong","year":"2022","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.lfs.2026.124283_bb0265","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/s44321-025-00256-w","article-title":"NRF2 modulates WNT signaling pathway to enhance photodynamic therapy resistance in oral leukoplakia","volume":"17","author":"Xu","year":"2025","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.lfs.2026.124283_bb0270","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.biochi.2015.10.014","article-title":"Taxifolin curbs NF-kappaB-mediated Wnt\/beta-catenin signaling via up-regulating Nrf2 pathway in experimental colon carcinogenesis","volume":"119","author":"Manigandan","year":"2015","journal-title":"Biochimie"},{"issue":"7","key":"10.1016\/j.lfs.2026.124283_bb0275","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1111\/jcmm.13628","article-title":"Nrf2 attenuates inflammatory response in COPD\/emphysema: crosstalk with Wnt3a\/beta-catenin and AMPK pathways","volume":"22","author":"Cui","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"8","key":"10.1016\/j.lfs.2026.124283_bb0280","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-024-06977-z","article-title":"DDX5 deficiency drives non-canonical NF-\u03baB activation and NRF2 expression, influencing sorafenib response and hepatocellular carcinoma progression","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2026.124283_bb0285","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cbi.2017.05.025","article-title":"Role of RAS\/Wnt\/beta-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy","volume":"273","author":"Chen","year":"2017","journal-title":"Chem. Biol. Interact."},{"issue":"7","key":"10.1016\/j.lfs.2026.124283_bb0290","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1142\/S0192415X24500757","article-title":"Botany, traditional use, phytochemistry, pharmacology and clinical applications of rhubarb (Rhei Radix et rhizome): a systematic review","volume":"52","author":"Xu","year":"2024","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.lfs.2026.124283_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1442297","article-title":"The application of rhubarb concoctions in traditional Chinese medicine and its compounds, processing methods, pharmacology, toxicology and clinical research","volume":"15","author":"Wen","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"15","key":"10.1016\/j.lfs.2026.124283_bb0300","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1055\/s-0028-1088340","article-title":"Phytochemical constituents from Cassia alata with inhibition against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"74","author":"Hazni","year":"2008","journal-title":"Planta Med."},{"issue":"7","key":"10.1016\/j.lfs.2026.124283_bb0305","first-page":"7296","article-title":"Neuroprotective, anti-inflammatory and antifibrillogenic offerings by Emodin against Alzheimer\u2019s dementia: a systematic review","volume":"9","author":"Saha","year":"2024","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.lfs.2026.124283_bb0310","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13020-025-01146-6","article-title":"Emodin promotes GSK-3beta-mediated PD-L1 proteasomal degradation and enhances anti-tumor immunity in hepatocellular carcinoma","volume":"20","author":"Yang","year":"2025","journal-title":"Chin. Med."},{"key":"10.1016\/j.lfs.2026.124283_bb0315","article-title":"Molecular mechanisms of action of Emodin: as an anti-cardiovascular disease drug","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124283_bb0320","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48709-x","article-title":"Emodin exhibits anti-acne potential by inhibiting cell growth, lipogenesis, and inflammation in human SZ95 sebocytes","volume":"13","author":"Liu","year":"2023","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.lfs.2026.124283_bb0325","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1080\/21655979.2022.2052671","article-title":"Protecting effect of emodin in experimental autoimmune encephalomyelitis mice by inhibiting microglia activation and inflammation via Myd88\/PI3K\/Akt\/NF-kappaB signalling pathway","volume":"13","author":"Zheng","year":"2022","journal-title":"Bioengineered"},{"issue":"3","key":"10.1016\/j.lfs.2026.124283_bb0330","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1872-034X.2008.00380.x","article-title":"Emodin reverses CCl induced hepatic cytochrome P450 (CYP) enzymatic and ultrastructural changes: the in vivo evidence","volume":"39","author":"Bhadauria","year":"2009","journal-title":"Hepatol. Res."},{"issue":"2","key":"10.1016\/j.lfs.2026.124283_bb0335","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2023.2290930","article-title":"Research progress of natural active compounds on improving podocyte function to reduce proteinuria in diabetic kidney disease","volume":"45","author":"Gong","year":"2023","journal-title":"Ren. Fail."},{"issue":"15","key":"10.1016\/j.lfs.2026.124283_bb0340","first-page":"7673","article-title":"Emodin attenuates diabetic kidney disease by inhibiting ferroptosis via upregulating Nrf2 expression","volume":"15","author":"Ji","year":"2023","journal-title":"Aging"},{"issue":"2","key":"10.1016\/j.lfs.2026.124283_bb0345","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.4081\/ejh.2024.3917","article-title":"Emodin improves renal fibrosis in chronic kidney disease by regulating mitochondrial homeostasis through the mediation of peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1\u03b1)","volume":"68","author":"Feng","year":"2024","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.lfs.2026.124283_bb0350","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.bbrc.2020.11.094","article-title":"Emodin ameliorates tubulointerstitial fibrosis in obstructed kidneys by inhibiting EZH2","volume":"534","author":"Xu","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2026.124283_bb0355","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.freeradbiomed.2025.09.016","article-title":"Aloe-emodin mitigates cisplatin-induced acute kidney injury by Nrf2-mediated ferroptosis regulation","volume":"241","author":"Dai","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2026.124283_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174603","article-title":"Emodin prevents renal ischemia-reperfusion injury via suppression of CAMKII\/DRP1-mediated mitochondrial fission","volume":"916","author":"Wang","year":"2022","journal-title":"Eur. J. Pharmacol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526000913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526000913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:58:41Z","timestamp":1777431521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320526000913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":72,"alternative-id":["S0024320526000913"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124283","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emodin retards renal cyst progression in ADPKD by inhibiting cell proliferation and decreasing oxidative stress","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124283","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124283"}}